Advanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measures.
Heikinheimo
Oskari
O
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. oskari.heikinheimo@helsinki.fi
Leminen
Arto
A
Cacciatore
Bruno
B
Rutanen
Eeva-Marja
EM
Kajanoja
Pauli
P
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000328:Adult; D002584:Cervix Uteri; D004359:Drug Therapy, Combination; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D015735:Mifepristone / Q000008:administration & dosage; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000628:therapy*
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone; D008727:Methotrexate